Prime Medicine

Prime Medicine
Biotechnology company.
Gene Editing
Biotechnology
Machine Learning
Data Analytics
Open roles at Prime Medicine
7 open roles
AI & Informatics Engineer
Machine Learning
Cambridge, MA
On-site
Mid Level
Full-time
1 month ago
Staff Accountant
Finance
Cambridge, MA
On-site
Staff
Full-time
1 month ago
Sr. Clinical Research Coordinator, Clinical Operations
Healthcare
Watertown, MA
On-site
Senior
Full-time
1 month ago
Senior Scientist, Safety Assessment
Healthcare
Cambridge, MA
On-site
Senior
Full-time
2 months ago
Senior Scientist, Drug Metabolism & Pharmacokinetics (DMPK)
Healthcare
Cambridge, MA
On-site
Senior
Full-time
2 months ago
Director, People and Culture Business Partner
HR
Cambridge, MA/Watertown, MA
On-site
Director
Full-time
2 months ago
Senior Laboratory Operations Associate
Healthcare
Watertown, MA
On-site
Senior
Full-time
3 months ago
Closed positions
22 positions
CMC Statistician Intern
Cambridge, Ma
Intern
Closed 2d ago
Sr. Manager, QC
Cambridge, MA
Senior
Closed 2d ago
Co-op: Regulatory Affairs
Cambridge, MA
Intern
Closed 2d ago
Senior Scientist, Biomarkers
Cambridge, MA
Senior
Closed 2d ago
Scientist II - Cell Process Development
Cambridge, MA
Mid Level
Closed 2d ago
Products and services

Prime Editing Platform
Gene Editing Technology
PM
PM359
Therapeutic Program
IN
In Vivo Delivery Systems
Delivery Technology
LI
Liver-directed Programs
Therapeutic Program
PM
PM381 (Hereditary Transthyretin Amyloidosis)
Therapeutic Program
PR
Prime Editor Proteins
Research Tool

Delivery System Development
Delivery Technology
GU
Guide RNA Design Tools
Research Tool
DE
Delivery Systems
Delivery Technology

Prime Editing for Rare Diseases
Therapeutic Program
PM
PM359 (Chronic Granulomatous Disease)
Therapeutic Program
PM
PM718
Therapeutic Program
HE
Hereditary Transthyretin Amyloidosis Program
Therapeutic Program

Guide RNA Design Services
Research Service
EY
Eye Disease Programs
Therapeutic Program

PM501
Therapeutic Program
WI
Wilson Disease Program
Therapeutic Program

PM411
Therapeutic Program
EX
Ex Vivo Cell Engineering
Cell Engineering
LE
Leber Congenital Amaurosis Program
Therapeutic Program
Leadership
Nsit
Not specified in text
CEO
Latest updates
All
X
News
HN
YouTube
Prime Medicine (NASDAQ:PRME) Stock Rating Lowered by Wall Street Zen - MarketBeat
MarketBeat
News
·
1 month ago
Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates - MSN
MSN
News
·
1 month ago
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates - MSN
MSN
News
·
1 month ago
Prime Medicine, Inc. (NASDAQ:PRME) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
MarketBeat
News